Since the natural course of type 1 diabetes is to lose most endogenous insulin production during the first 5 years [46], it will be of utmost interest to investigate whether the treatment effect is preserved and to determine the impact on metabolic control when differences in endogenous insulin production are magnified. The gene discussed is INS; the disease is type 1 diabetes mellitus.